SLXN
Price:
$3.13
Market Cap:
$1.31M
Silexion Therapeutics LTD is a biopharmaceutical company specializing in the discovery and advancement of RNA interference (RNAi)-based cancer therapies and their associated delivery systems, with a focus on treating aggressive solid tumors. The company's strategy for addressing these tumors relies on its proprietary LODER delivery platform. Its product pipeline features several key candidates: SiG12D-LODER, which has progressed through both preclinical studies and an open-label Phase I clinical trial for pancreatic cancer; Prostate-LODER, currently undergoing preclinical evaluation for prostate cancer; and GBM-LODER, also in preclinical development, targeting Glioblastoma Multiforme, a high...[Read more]
Industry
Biotechnology
IPO Date
2024-08-16
Stock Exchange
NASDAQ
Ticker
SLXN
According to Silexion Therapeutics Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -0.05. This represents a change of -88.35% compared to the average of -0.43 of the last 4 quarters.
The mean historical PE Ratio of Silexion Therapeutics Ltd. over the last ten years is -4896.49. The current -0.05 PE Ratio has changed -99.90% with respect to the historical average. Over the past ten years (40 quarters), SLXN's PE Ratio was at its highest in in the June 2022 quarter at 25.44K. The PE Ratio was at its lowest in in the March 2023 quarter at -1025101.96.
Average
-4896.49
Median
-714.61
Minimum
-22184.65
Maximum
-0.21
Discovering the peaks and valleys of Silexion Therapeutics Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.21
Minimum Annual Increase = -98.13%
Minimum Annual PE Ratio = -22184.65
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.21 | -98.13% |
| 2024 | -11.44 | -80.78% |
| 2023 | -59.51 | -95.65% |
| 2022 | -1369.70 | -76.19% |
| 2021 | -5753.42 | -74.07% |
The current PE Ratio of Silexion Therapeutics Ltd. (SLXN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-23.72
5-year avg
-1438.86
10-year avg
-4896.49
Silexion Therapeutics Ltd.’s PE Ratio is greater than Indaptus Therapeutics, Inc. (-0.41), greater than Salarius Pharmaceuticals, Inc. (-0.25), less than SciSparc Ltd. (-0.03), greater than Lipella Pharmaceuticals Inc. (-0.07), greater than Jasper Therapeutics, Inc. (-0.16), greater than Azitra, Inc. (-0.28), greater than Protagenic Therapeutics, Inc. (-0.19), greater than Onconetix, Inc. (-0.07), less than Scinai Immunotherapeutics Ltd. (-0.00), greater than Enveric Biosciences, Inc. (-0.28),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.41 | $6.27M | |
| -0.25 | $4.92M | |
| -0.03 | $494.52K | |
| -0.07 | $369.67K | |
| -0.16 | $7.44M | |
| -0.28 | $2.27M | |
| -0.19 | $905.10K | |
| -0.07 | $340.71K | |
| -0.00 | $435.39K | |
| -0.28 | $913.43K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Silexion Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Silexion Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Silexion Therapeutics Ltd.'s PE Ratio?
How is the PE Ratio calculated for Silexion Therapeutics Ltd. (SLXN)?
What is the highest PE Ratio for Silexion Therapeutics Ltd. (SLXN)?
What is the 3-year average PE Ratio for Silexion Therapeutics Ltd. (SLXN)?
What is the 5-year average PE Ratio for Silexion Therapeutics Ltd. (SLXN)?
How does the current PE Ratio for Silexion Therapeutics Ltd. (SLXN) compare to its historical average?